FDA issues enforcement guidance for molecular influenza and RSV tests administered during COVID-19 pandemic

by on

FDA issues enforcement guidance for molecular influenza and RSV tests administered during COVID-19 pandemic
tjordan_drupal
Oct 14, 2020

The Food and Drug Administration Oct. 13 issued and immediately implemented enforcement policy for modifications to FDA-cleared molecular influenza and RSV tests during the COVID-19 public health emergency to expand access to certain FDA-cleared molecular tests for detecting and identifying flu viruses and respiratory syncytial viruses.

The agency notes that these tests often require the same critical components as many SARS-CoV-2 molecular assays.

Headline

FDA issues enforcement guidance for molecular influenza and RSV tests administered during COVID-19 pandemic
tjordan_drupal
Oct 14, 2020

The Food and Drug Administration Oct. 13 issued and immediately implemented enforcement policy for modifications to FDA-cleared molecular influenza and RSV tests during the COVID-19 public health emergency to expand access to certain FDA-cleared molecular tests for detecting and identifying flu viruses and respiratory syncytial viruses.

The agency notes that these tests often require the same critical components as many SARS-CoV-2 molecular assays.

Novel Coronavirus (COVID-19)
COVID-19: CDC, FDA and CMS Guidance

Headline

VA:F [1.9.7_1111]
Rating: 0.0/10 (0 votes cast)
VA:F [1.9.7_1111]
Rating: 0 (from 0 votes)

Leave a Comment

Previous post:

Next post: